Cancer Screening

When lung cancer is found early, the odds of successful treatment and survival are higher. However, in the early stages of lung cancer, symptoms are not always apparent, making diagnosis difficult and often delayed.

Cancer screening for high-risk patients with scleroderma should involve basic age, sex and risk factor targeted screening, paying particular attention to mammography in women and prostate-specific antigen in men, according to Ami Shah, MD, of John Hopkins University, at the virtual ACR State-of-the-Art Clinical Symposium.

Care coordination compared with usual care had a 20.4% higher completion of surveillance colonoscopy in primary care patients at a large health system with high-risk adenoma, according to data from Digestive Disease Week.

A minimally invasive, multicancer blood test demonstrated utility for screening and helping to guide management of individuals with no cancer history, according to results of a prospective study presented at the virtual American Association for Cancer Research Annual Meeting.

A cell-free DNA multicancer early detection test demonstrated an ability to predict cancer and the tissue of origin in individuals with clinical suspicion of cancer, according to results of the Circulating Cell-free Genome Atlas study presented at the virtual American Association for Cancer Research Annual Meeting.

Women older than 75 years who were provided with a mammography screening decision aid before visiting their primary care physician were more likely to make more informed screening decisions than those who did not receive the decision aid, according to randomized clinical trial results published in JAMA Internal Medicine.

Public-facing websites of cancer screening programs in the United States often fail to present balanced information about the possible benefits and harms of screening, according to an analysis published in the Annals of Internal Medicine.

Colorectal cancer could have been diagnosed earlier or possibly prevented among adults aged 40 to 49 years had these individuals undergone screening in accordance with family history-based guidelines, according to results of a retrospective analysis published in Cancer.

A novel blood test accurately detected more than 50 types of cancer with a specificity of 99.3%, according to results of the prospective Circulating Cell-free Genome Atlas study published in Annals of Oncology.

Three-quarters of patients would recommend artificial intelligence as a component of clinical decision-making for skin cancer, according to a survey.